Priority Date: 08.03.12 (US 201261685089P)

CONDITIONALLY ACTIVE ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODIES AND METHODS OF USE THEREOF

  • Application ID: EP13710278
  • Status: EXAMINATION IN PROGRESS

Applicant

Technology company logo small
Technology Company

Attorney

Employment test 51 - 200 employees
Company dna boult wade tennant ltd
no operation time available
Headquarter in London and 4 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This patent has the IPC combination C07 (ORGANIC CHEMISTRY) and G01 (MEASURING; TESTING) is specialized in the combination C07 and G01. We found, that TransMIT GmbH, Kailuweit & Uhlemann, dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB, Kilburn & Strode LLP, Vereenigde Octrooibureaux NV (V.O.) and 69 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 08.03.2012 - Priority Date (US 201261685089P)
  • 12.09.2013 - Publication A1 (WO2013134743)
  • 14.01.2015 - Publication A1 (EP2822970)